A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT

Clinical trial NCT05171894 · RECRUITING

Trial details

NCT number: NCT05171894
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Port-wine Birthmarks Port-Wine Stain Nevus Flammeus

Start date: 2024-09-21
Primary completion: 2027-01-01
Enrollment: 84

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.